Zhai, Wei
Yang, Wensheng
Ge, Jing
Xiao, Xuelian
Wu, Kang
She, Kelin
Zhou, Yu
Kong, Yi
Wu, Lin
Luo, Shiya
Pu, Xingxiang
Funding for this research was provided by:
Hunan Cancer Hospital Climb Plan (YF2020005)
Beijing Xisike Clinical Oncology Research Foundation (Y-XD202001-0215)
Hunan Provincial Natural Science Foundation of China (2024JJ9137)
Wu JiePing Medical Fund (320.6750.2023-05-43)
The science and technology innovation Program of Hunan Province (2023SK4024)
Article History
Received: 31 May 2023
Accepted: 8 August 2024
First Online: 16 October 2024
Declarations
:
: The study involved human tissue samples use and animal experiments performing were all approved by the Ethics Committee of Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya school of Medicine, Central South University. The informed consents were obtained from patients. All the methods and procedures performed during this study were in accordance with relevant regulation and guidelines.
: Not applicable.
: The authors declare that they have no conflict of interest.